Search Results - Vaks, Lilach

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease

    Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease by Rippin, Ido, Bonder, Katherina, Joseph, Shirley, Sarsor, Ammar, Vaks, Lilach, Eldar-Finkelman, Hagit

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines

    In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines by Vaks, Lilach, Benhar, Itai

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds

    Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds by Vaks, Lilach, Litvak-Greenfeld, Dana, Dror, Stav, Shefet-Carasso, LeeRon, Matatov, Galia, Nahary, Limor, Shapira, Shiran, Hakim, Rahely, Alroy, Iris, Benhar, Itai

    Published in Antibodies (Basel)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A unique type of GSK-3 inhibitor brings new opportunities to the clinic

    A unique type of GSK-3 inhibitor brings new opportunities to the clinic by Licht-Murava, Avital, Paz, Rom, Vaks, Lilach, Avrahami, Limor, Plotkin, Batya, Eisenstein, Miriam, Eldar-Finkelman, Hagit

    Published in Science signaling
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: